Use of Hypertonic Saline After Damage Control Laparotomy to Improve Early Primary Fascial Closure

December 13, 2015 updated by: Valerie Sams, San Antonio Military Medical Center
Damage control laparotomy (DCL) has proven to be a successful means to improve survival in severely injured patients.1-5 However, the consequences of not being able to close the fascia after the initial operation due to significant resuscitation leading to bowel and retroperitoneal edema, abdominal compartment syndrome, and continued acidosis, coagulopathy and hypethermia6-7 has led to a new challenge. Delays in primary fascial closure (PFC) contributes to increased fluid losses and nutritional demands,8-9 abdominal wall hernias, enterocutaneous fistula, and intra-abdominal infections.10-13 Hypertonic saline (HTS) use after DCL has been suggested to reduce bowel edema and resuscitation volumes, thus allowing for a quicker time to closure.14 Investigators will randomize patients to receiving HTS or standard crystalloid solutions after DCL and compare the time to PFC, rate of successful closure, and rate of complications associated with an open abdomen. The current failure rate of PFC after DCL is approximately 25%. Investigators believe they can improve PFC rates using hypertonic saline.

Study Overview

Detailed Description

The use of HTS after DCL may decrease the rate of failure to achieve PFC and reduce the number of complications associated with an open abdomen.

Research Questions:

  1. Primary Objective: Is there a higher rate of PFC among patients who undergo DCL and temporary abdominal closure when using HTS versus standard crystalloid resuscitation?
  2. Secondary Objectives: Does successful and faster PFC reduce ICU, ventilator and hospital days?
  3. Does faster and more successful PFC result in lower morbidity to include enterocutaneous fistula (ECF), intra-abdominal abscess (IAA), abdominal wall hernia, and anastomotic failure?

DCL is a common procedure wounded warriors undergo due to blast and other blunt and penetrating mechanisms of injury. This results in a significant population of warriors at risk for all of the complications and comorbidities that accompany an open abdomen. Thus, finding ways to not only achieve PFC but also to decrease the time to PFC will reduce these unwanted events.

The protocol design is a multi-institutional, prospective, double blind, randomized controlled trial of patients who undergo DCL for abdominal trauma requiring temporary abdominal closure and return to operating room for definitive treatment. All participating facilities are Level I Trauma Centers. Currently, the standard of care for damage control resuscitation involves all intravenous fluid solutions utilized in this study; normal saline, Ringer's lactate, Plasmalyte, and 3% saline (HTS). However, the type of fluid is selected based on surgeon preference alone. Investigators will randomize patients to normal saline at a resuscitation rate of 30 cc/hr or to 3% saline (HTS) at a resuscitation rate of 30cc/hr which will be initiated upon arrival to the ICU.

Study Type

Interventional

Enrollment (Anticipated)

312

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • San Antonio, Texas, United States, 78234
        • Recruiting
        • San Antonio Military Medical Center
        • Contact:
        • Contact:
        • Principal Investigator:
          • Valerie G Sams, MD
        • Sub-Investigator:
          • Michelle F Buehner, MD
        • Sub-Investigator:
          • Christopher E White, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All admissions of trauma patients who sustain trauma necessitating damage control laparotomy.
  • Male and female patients 18 years or older.

Exclusion Criteria:

  • Children (<18 years old), prisoners, or pregnant patients.
  • Patients who have more than 1/3 loss of abdominal wall due to trauma.
  • Patients with baseline serum sodium of <120 mEq/L or >155 mEq/L.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Crystalloid resuscitation
Patients to receive normal saline resuscitation at a rate of 30cc/hr.
Abdominal wall closure following damage control laparotomy.
temporary abdominal wall closure with this device after damage control laparotomy
Other Names:
  • AbThera woulnd vac (KCI)
Active Comparator: Hypertonic saline resuscitation
Patients to receive 3% hypertonic saline resuscitation at a rate of 30cc/hr.
Abdominal wall closure following damage control laparotomy.
temporary abdominal wall closure with this device after damage control laparotomy
Other Names:
  • AbThera woulnd vac (KCI)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants who achieve primary fascial closure
Time Frame: 2 weeks
Is there a higher rate of PFC among patients who undergo DCL and temporary abdominal closure when using HTS versus standard crystalloid resuscitation?
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of ICU free days
Time Frame: 30 days
Does successful and faster PFC reduce ICU days?
30 days
number of enterocutaneous fistula
Time Frame: 90 days
Does faster and more successful PFC result in reduction enterocutaneous fistula (ECF)?
90 days
number of intra abdominal abscess
Time Frame: 90 days
Does faster and more successful PFC result in reduction of intra-abdominal abscess (IAA)?
90 days
number of abdominal wall hernias
Time Frame: 90 days
Does faster and more successful PFC result in reduction in abdominal wall hernia?
90 days
number of anastomotic failure
Time Frame: 90 days
Does faster and more successful PFC result in a reduction in anastomotic failure?
90 days
number of ventilator free days
Time Frame: 30 days
Does successful and faster PFC reduce ventilator days?
30 days
number of hospital free days
Time Frame: 30 days
Does successful and faster PFC reduce hospital days?
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Anticipated)

December 1, 2016

Study Completion (Anticipated)

January 1, 2017

Study Registration Dates

First Submitted

August 1, 2014

First Submitted That Met QC Criteria

November 18, 2014

First Posted (Estimate)

November 21, 2014

Study Record Updates

Last Update Posted (Estimate)

December 15, 2015

Last Update Submitted That Met QC Criteria

December 13, 2015

Last Verified

December 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 397284-1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Open Abdomen After Damage Control Laparotomy

Clinical Trials on Primary Fascial Closure

Subscribe